These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38956560)

  • 41. Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma.
    Tone AA; Begley H; Sharma M; Murphy J; Rosen B; Brown TJ; Shaw PA
    Clin Cancer Res; 2008 Jul; 14(13):4067-78. PubMed ID: 18593983
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
    Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
    Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Directed Differentiation of Human Induced Pluripotent Stem Cells into Fallopian Tube Epithelium.
    Yucer N; Holzapfel M; Jenkins Vogel T; Lenaeus L; Ornelas L; Laury A; Sareen D; Barrett R; Karlan BY; Svendsen CN
    Sci Rep; 2017 Sep; 7(1):10741. PubMed ID: 28878359
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Progesterone Prevents High-Grade Serous Ovarian Cancer by Inducing Necroptosis of p53-Defective Fallopian Tube Epithelial Cells.
    Wu NY; Huang HS; Chao TH; Chou HM; Fang C; Qin CZ; Lin CY; Chu TY; Zhou HH
    Cell Rep; 2017 Mar; 18(11):2557-2565. PubMed ID: 28297660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR.
    Bapat J; Yamamoto TM; Woodruff ER; Qamar L; Mikeska RG; Aird KM; Watson ZL; Brubaker LW; Bitler BG
    Cancer Gene Ther; 2024 Feb; 31(2):300-310. PubMed ID: 38030811
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The conceptual advances of carcinogenic sequence model in high-grade serous ovarian cancer.
    Kobayashi H; Iwai K; Niiro E; Morioka S; Yamada Y; Ogawa K; Kawahara N
    Biomed Rep; 2017 Sep; 7(3):209-213. PubMed ID: 28811894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The fallopian tube, "precursor escape" and narrowing the knowledge gap to the origins of high-grade serous carcinoma.
    Soong TR; Howitt BE; Horowitz N; Nucci MR; Crum CP
    Gynecol Oncol; 2019 Feb; 152(2):426-433. PubMed ID: 30503267
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exposure of the extracellular matrix and colonization of the ovary in metastasis of fallopian-tube-derived cancer.
    Dean M; Jin V; Russo A; Lantvit DD; Burdette JE
    Carcinogenesis; 2019 Mar; 40(1):41-51. PubMed ID: 30475985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytidine deaminase Apobec3a induction in fallopian epithelium after exposure to follicular fluid.
    Brachova P; Alvarez NS; Van Voorhis BJ; Christenson LK
    Gynecol Oncol; 2017 Jun; 145(3):577-583. PubMed ID: 28215840
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human Fallopian Tube-Derived Organoids with TP53 and RAD51D Mutations Recapitulate an Early Stage High-Grade Serous Ovarian Cancer Phenotype In Vitro.
    Dai Y; Xu J; Gong X; Wei J; Gao Y; Chai R; Lu C; Zhao B; Kang Y
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The diagnostic and biological implications of laminin expression in serous tubal intraepithelial carcinoma.
    Kuhn E; Kurman RJ; Soslow RA; Han G; Sehdev AS; Morin PJ; Wang TL; Shih IeM
    Am J Surg Pathol; 2012 Dec; 36(12):1826-34. PubMed ID: 22892598
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
    Wen J; Shi JL; Shen DH; Chen YX; Song QJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    Saini U; Suarez AA; Naidu S; Wallbillich JJ; Bixel K; Wanner RA; Bice J; Kladney RD; Lester J; Karlan BY; Goodfellow PJ; Cohn DE; Selvendiran K
    Cancer Res; 2018 Apr; 78(7):1739-1750. PubMed ID: 29339537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Current FIGO staging classification for cancer of ovary, fallopian tube and peritoneum].
    Šišovská I; Minář L; Felsinger M; Anton M; Bednaříková M; Hausnerová J; Jandáková E; Weinberger V
    Ceska Gynekol; 2017; 82(3):230-236. PubMed ID: 28593778
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two different, mutually exclusively distributed,
    Sukhbaatar N; Bachmayr-Heyda A; Auer K; Aust S; Deycmar S; Horvat R; Pils D
    Cold Spring Harb Mol Case Stud; 2017 Jul; 3(4):. PubMed ID: 28679689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers.
    Karst AM; Jones PM; Vena N; Ligon AH; Liu JF; Hirsch MS; Etemadmoghadam D; Bowtell DD; Drapkin R
    Cancer Res; 2014 Feb; 74(4):1141-52. PubMed ID: 24366882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of Follicular Fluid on Physiological Characteristics and Differentiation of Fallopian Tube Epithelial Cells Implicating for Ovarian Cancer Pathogenesis.
    Zhu M; Wang N; Wang S; Wang Y; Yang X; Fan J; Chen Y
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ki-67 labeling index as an adjunct in the diagnosis of serous tubal intraepithelial carcinoma.
    Kuhn E; Kurman RJ; Sehdev AS; Shih IeM
    Int J Gynecol Pathol; 2012 Sep; 31(5):416-22. PubMed ID: 22833080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DNA Methylome Analyses Implicate Fallopian Tube Epithelia as the Origin for High-Grade Serous Ovarian Cancer.
    Klinkebiel D; Zhang W; Akers SN; Odunsi K; Karpf AR
    Mol Cancer Res; 2016 Sep; 14(9):787-94. PubMed ID: 27259716
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Defining the molecular evolution of extrauterine high grade serous carcinoma.
    Beirne JP; McArt DG; Roddy A; McDermott C; Ferris J; Buckley NE; Coulter P; McCabe N; Eddie SL; Dunne PD; O'Reilly P; Gilmore A; Feeney L; Ewing DL; Drapkin RI; Salto-Tellez M; Kennedy RD; Harley IJG; McCluggage WG; Mullan PB
    Gynecol Oncol; 2019 Nov; 155(2):305-317. PubMed ID: 31493898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.